Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas

Cancers
Teresa PoggioAnna L Illert

Abstract

T cell non-Hodgkin lymphoma (T-NHL) is a rare and heterogeneous group of neoplasms of the lymphoid system. With the exception of a few relatively indolent entities, T-NHL is typically aggressive, treatment resistant, and associated with poor prognosis. Relatively few options with proven clinical benefit are available for patients with relapsed or refractory disease. Immunotherapy has emerged as a promising treatment for the management of patients with hematological malignancies. The identification of tumor antigens has provided a large number of potential targets. Therefore, several monoclonal antibodies (alemtuzumab, SGN-30, brentuximab vedotin, and mogamulizumab), directed against tumor antigens, have been investigated in different subtypes of T-NHL. In addition to targeting antigens involved in cancer cell physiology, antibodies can stimulate immune effector functions or counteract immunosuppressive mechanisms. Chimeric antigen receptor (CAR)-T cells directed against CD30 and immune checkpoint inhibitors are currently being investigated in clinical trials. In this review, we summarize the currently available clinical evidence for immunotherapy in T-NHL, focusing on the results of clinical trials using first generation monocl...Continue Reading

References

Apr 5, 1995·Journal of the National Cancer Institute·L B TravisJ Adami
Dec 31, 1997·Cancer Nursing·J SitziaN Winterberg
Mar 23, 2000·The Journal of Pathology·H DürkopH Stein
Sep 15, 2000·Journal of Immunological Methods·D Campana, F G Behm
Feb 8, 2002·Cell·Ricky W JohnstoneScott W Lowe
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takashi IshidaRyuzo Ueda
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kevin J HamblettJoseph A Francisco
Feb 5, 2005·Blood·Rein WillemzeChris J L M Meijer
Mar 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadejda Y MudieDavid C Linch
Apr 5, 2007·Cancer Chemotherapy and Pharmacology·Jong Gwang KimSuk Joong Oh
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kunihiro TsukasakiUNKNOWN Japan Clinical Oncology Group Study JCOG9801
Mar 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kari HemminkiJusto Lorenzo Bermejo
May 27, 2008·Nature Reviews. Immunology·Weiping Zou, Lieping Chen
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Dec 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michal MarzecMariusz A Wasik
May 27, 2009·British Journal of Haematology·Andres Forero-TorresAjay K Gopal
Oct 1, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Madeleine DuvicYoun H Kim
Mar 18, 2010·The Journal of Clinical Investigation·Rupal RamakrishnanDmitry I Gabrilovich
Nov 19, 2011·American Journal of Clinical Pathology·Alexandra C HristovMichael J Borowitz
Feb 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Takashi IshidaRyuzo Ueda
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Apr 28, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Santiago Montes-MorenoMiguel A Piris
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara ProAndrei Shustov
Apr 4, 2013·Cancer Discovery·Michel SadelainIsabelle Rivière
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vivien MakKerry J Savage
May 16, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin J ChenScott J Rodig
Nov 10, 2013·Nature Medicine·Daniela F Quail, Johanna A Joyce
Jan 21, 2014·The British Journal of Dermatology·A de MassonM Bagot
Mar 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michinori OguraRyuzo Ueda

❮ Previous
Next ❯

Citations

Oct 24, 2019·Recent Patents on Anti-cancer Drug Discovery·Romeo G Mihăilă
Nov 2, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Angelo FamaJames R Cerhan
Feb 2, 2021·Expert Opinion on Pharmacotherapy·Anna Wolska-WasherTadeusz Robak
Apr 4, 2021·International Journal of Molecular Sciences·Clifford M Csizmar, Stephen M Ansell
Apr 20, 2021·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Man ChenHui Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Clinical Trials Mentioned

NCT01777152
NCT01578499
NCT01728805
NCT03049449

Software Mentioned

MAVORIC
Yescarta

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2022 Meta ULC. All rights reserved